GE HEALTHCARE TECH.INC. (L0T) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.66x

GE HEALTHCARE TECH.INC. (L0T) has a Cash Flow Reinvestment Rate of 0.66x as of March 2026, reinvesting €191.00 Million (capex €178.00 Million plus investments €-13.00 Million) from operating cash flow of €290.00 Million. Explore GE HEALTHCARE TECH.INC. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

€191.00 Million
Capex + Investments

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

GE HEALTHCARE TECH.INC. Cash Flow Reinvestment Rate (2022–2025)

Historical reinvestment intensity for GE HEALTHCARE TECH.INC. across 4 annual periods. Also explore L0T current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GE HEALTHCARE TECH.INC. (2022–2025)

Year-by-year capital reinvestment analysis for GE HEALTHCARE TECH.INC.. For live market cap and broader valuation context, see GE HEALTHCARE TECH.INC. (L0T) market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.30x €600.00 Million €1.99 Billion €482.00 Million ▲ +33.6%
2024 0.23x €441.00 Million €1.95 Billion €401.00 Million ▲ +9.2%
2023 0.21x €435.00 Million €2.10 Billion €387.00 Million ▲ +18.6%
2022 0.17x €369.00 Million €2.11 Billion €310.00 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow